Clin Orthop Surg.  2015 Sep;7(3):318-322. 10.4055/cios.2015.7.3.318.

Utilization of Hyaluronate and Incidence of Septic Knee Arthritis in Adults: Results from the Korean National Claim Registry

Affiliations
  • 1Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 2Department of Orthopedic Surgery, Dankook University School of Medicine, Cheonan, Korea. puhoo73@hanmail.net
  • 3Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Septic arthritis of the knee has been reported recently in adult patients who were administered hyaluronate. We evaluated the incidence of septic knees and the utilization of hyaluronate in the Korean adult population using nationwide data from the Health Insurance Review and Assessment Service (HIRA).
METHODS
All new admissions to the clinics or hospitals for septic knees were recorded in the HIRA database which was established by the Korean government and covers the Korean population using the International Classification of Diseases-10 revision code. We evaluated the incidence of septic arthritis of the knees in the population above 50 years of age. Hyaluronate prescription data was also collected from the HIRA database.
RESULTS
In 2012, the incidence of septic knees was 2.7 per 100,000 persons in men and 4.2 per 100,000 persons in women, respectively. The age-adjusted incidence of septic knees increased by 6.7% per year (95% confidence interval, 3.3 to 10.1), and the annual number of prescriptions of hyaluronate increased about 1.5-fold during the study period.
CONCLUSIONS
Cautious aseptic technique is required when hyaluronate is administered in adult patients with osteoarthritis of the knee due to the concerns of the risk of septic arthritis.

Keyword

Septic; Arthritis; Hyaluronic acid; Knee

MeSH Terms

Arthritis, Infectious/*epidemiology/etiology
Female
Humans
Hyaluronic Acid/administration & dosage/*therapeutic use
Incidence
Injections, Intra-Articular/*adverse effects/statistics & numerical data
Knee Joint/physiopathology
Male
Middle Aged
Osteoarthritis, Knee/drug therapy
Republic of Korea/epidemiology
Hyaluronic Acid

Figure

  • Fig. 1 The number of septic knees (A) and the age-adjusted incidence of septic knees (B) in the population above 50 years of age from 2008 to 2012.

  • Fig. 2 The number of prescriptions of hyaluronate from 2008 to 2012.


Cited by  1 articles

Operational Definition Identifying Osteoporotic Vertebral Fractures in the Claims Database
Min Heui Yu, Namki Hong, Seunghyun Lee, Ha-Young Kim, Hye-Sun Park, Sang-Min Park, Young-Kyun Lee, Tae-Young Kim, Yong-Chan Ha, Yumie Rhee, Kyung-Hoi Koo
J Korean Med Sci. 2022;37(32):e249.    doi: 10.3346/jkms.2022.37.e249.


Reference

1. Lee SC, Shim JS, Seo SW, Lee SS. Prognostic factors of septic arthritis of hip in infants and neonates: minimum 5-year follow-up. Clin Orthop Surg. 2015; 7(1):110–119.
2. Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet. 2010; 375(9717):846–855.
3. Matthews PC, Dean BJ, Medagoda K, et al. Native hip joint septic arthritis in 20 adults: delayed presentation beyond three weeks predicts need for excision arthroplasty. J Infect. 2008; 57(3):185–190.
4. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology (Oxford). 2001; 40(1):24–30.
5. Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, Dijkmans BA. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. 1997; 56(8):470–475.
6. Morgan DS, Fisher D, Merianos A, Currie BJ. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect. 1996; 117(3):423–428.
7. Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis. 1999; 58(4):214–219.
8. Geirsson AJ, Statkevicius S, Vikingsson A. Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections. Ann Rheum Dis. 2008; 67(5):638–643.
9. McAlindon TE, Bannuru RR. OARSI recommendations for the management of hip and knee osteoarthritis: the semantics of differences and changes. Osteoarthritis Cartilage. 2010; 18(4):473–475.
10. Richmond J, Hunter D, Irrgang J, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. J Bone Joint Surg Am. 2010; 92(4):990–993.
11. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010; 18(4):476–499.
12. Evanich JD, Evanich CJ, Wright MB, Rydlewicz JA. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res. 2001; (390):173–181.
13. Charalambous CP, Tryfonidis M, Sadiq S, Hirst P, Paul A. Septic arthritis following intra-articular steroid injection of the knee: a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee. Clin Rheumatol. 2003; 22(6):386–390.
14. Inoue K, Hukuda S, Fardellon P, et al. Prevalence of largejoint osteoarthritis in Asian and Caucasian skeletal populations. Rheumatology (Oxford). 2001; 40(1):70–73.
15. Huang TL, Chang CC, Lee CH, Chen SC, Lai CH, Tsai CL. Intra-articular injections of sodium hyaluronate (Hyalgan(R)) in osteoarthritis of the knee: a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord. 2011; 12:221.
16. Lai HY, Chen YC, Chen TJ, Chou LF, Chen LK, Hwang SJ. Intra-articular hyaluronic acid for treatment of osteoarthritis: a nationwide study among the older population of Taiwan. BMC Health Serv Res. 2008; 8:24.
17. Kim SH, Ko YB, Lee YK, et al. National utilization of calcium supplements in patients with osteoporotic hip fracture in Korea. J Bone Metab. 2013; 20(2):99–103.
18. Lee YK, Ha YC, Park C, Yoo JJ, Shin CS, Koo KH. Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry. Osteoporos Int. 2013; 24(2):707–711.
19. Lee YK, Jang S, Jang S, et al. Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int. 2012; 23(7):1859–1865.
20. Park C, Ha YC, Jang S, Jang S, Yoon HK, Lee YK. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29(6):744–751.
Article
21. Kim I, Kim HA, Seo YI, Song YW, Jeong JY, Kim DH. The prevalence of knee osteoarthritis in elderly community residents in Korea. J Korean Med Sci. 2010; 25(2):293–298.
Article
22. Korean Statistical Information Service [Internet]. Daejeon: Statistics Korea;2014. cited 2015 May 30. Available from: http://kosis.kr/.
23. Al Arfaj AS. A prospective study of the incidence and characteristics of septic arthritis in a teaching hospital in Riyadh, Saudi Arabia. Clin Rheumatol. 2008; 27(11):1403–1410.
Article
24. Newman JH. Review of septic arthritis throughout the antibiotic era. Ann Rheum Dis. 1976; 35(3):198–205.
Article
25. Morshed S, Huffman GR, Ries MD. Septic arthritis of the hip and intrapelvic abscess following intra-articular injection of hylan G-F 20: a case report. J Bone Joint Surg Am. 2004; 86(4):823–826.
Article
26. Shemesh S, Heller S, Salai M, Velkes S. Septic arthritis of the knee following intraarticular injections in elderly patients: report of six patients. Isr Med Assoc J. 2011; 13(12):757–760.
Full Text Links
  • CIOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr